Sign inJoin waitlistJoin the waitlist

ET

Erev Tubb

Physician · Inspira Health

Credentials: · · · · · ·

History

Inspira Health
2020–Present

Hematology and Medical Oncology
2005–2008
Internal Medicine
2002–2005
Sidney Kimmel Medical College at Thomas Jefferson University
1998–2002

Research

Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40
Nature Medicine · 1999 · 322 citations
In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance
Proceedings of the National Academy of Sciences of the United States of America · 1999 · 130 citations
Growth factor mRNA expression in human head and neck malignant tumors
Archives of Otolaryngology - Head and Neck Surgery · 1993 · 21 citations

Eduardo Sotomayor
2 papers
HL
Hyam Levitsky
2 papers
IB
Ivan Borrello
2 papers · 2 as a fellow
CN
Chaitali Nangia
1 paper
EK
Ebenezer Kio
1 paper
Gina Chung
1 paper
GT
Giovana Thomas
1 paper · 1 as a resident
HB
Harold Bien
1 paper
JL
Jim Lu
1 paper
Kevin Cullen
1 paper
MG
Mylene Go
1 paper
NA
Naheed Alam
1 paper

Grants

Updates on Breast and Cervical Cancer Screening, Diagnosis and Treatment Conferen
NCCDPHP · U13
Contact PI · $25K · St. Francis Hospital (Wilmington, de)
2010–2011

Clinical trials

The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
Site PI · Recruiting
Luminate Medical, Inc.
2025–2026
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Site PI · Recruiting · Phase 2
Genelux Corporation
2024–2029